VIDEO: Durability of bispecific antibodies highlighted at ASH

In this video, Stephen M. Ansell, MD, PhD, discusses research on the durability of bispecific antibodies, presented at ASH Annual Meeting and Exposition.
“We’re really seeing benefit that is durable in some cases where the bispecific antibody completed a course and stopped, and patients were just followed,” professor of medicine in the department of hematology at Mayo Clinic, Minnesota, said, adding that many of those patients remain in remission.
“This really opens up a field that is going to be very interesting in the future, and that is balancing bispecific antibodies and [chimeric

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart
This website uses cookies and asks your personal data to enhance your browsing experience.